
Novartis sheds staff as Entresto patent expiry looms
Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto.
Newsletters and Deep Dive digital magazine
Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto.
February saw a flurry of significant hires in the agency world, with several key players making strategic appointments to bolster their leadership teams.
Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."
The 39th PM Society Awards, supported by headline sponsor Avalere Health, were held on Friday 14th March, at the JW Marriott Grosvenor House in London.
The idea that the US might join peers around the world in banning direct-to-consumer advertising is one that the pharma industry is taking seriously.
Editor's Picks
Newsletters and Deep Dive
digital magazine